moxisylyte has been researched along with Prostatic Hyperplasia in 5 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical effectiveness of moxisylyte hydrochloride (Moxyl, Fuji Rebio), a selective alpha 1-adrenoceptor blocking agent, was investigated in patients with symptomatic benign prostatic hyperplasia." | 7.67 | [The effect of moxisylyte hydrochloride in the symptomatic treatment of benign prostatic hyperplasia]. ( Fuino, A; Ishibashi, A; Izumi, H; Kudo, S; Yokoyama, E, 1989) |
| "The clinical effectiveness of moxisylyte hydrochloride (Moxyl, Fuji Rebio), a selective alpha 1-adrenoceptor blocking agent, was investigated in patients with symptomatic benign prostatic hyperplasia." | 3.67 | [The effect of moxisylyte hydrochloride in the symptomatic treatment of benign prostatic hyperplasia]. ( Fuino, A; Ishibashi, A; Izumi, H; Kudo, S; Yokoyama, E, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lévy-Bruhl, A | 1 |
| Germanaud, J | 1 |
| Gargot, D | 1 |
| Legoux, JL | 1 |
| Larrey, D | 1 |
| Mignot, G | 1 |
| Dumas, G | 1 |
| Chichmanian, RM | 1 |
| Spreux, A | 1 |
| Perrigot, M | 1 |
| Vannier, A | 1 |
| Bor, Y | 1 |
| Izumi, H | 1 |
| Kudo, S | 1 |
| Fuino, A | 1 |
| Yokoyama, E | 1 |
| Ishibashi, A | 1 |
5 other studies available for moxisylyte and Prostatic Hyperplasia
| Article | Year |
|---|---|
[Moxisylyte-induced cytolytic hepatitis?].
Topics: Aged; Chemical and Drug Induced Liver Injury; Humans; Male; Moxisylyte; Prostatic Hyperplasia | 1991 |
[Late discovery of drug-related hepatotoxicity].
Topics: Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Humans; Male; Moxisylyte; | 1991 |
[Moxisylyte: affecting the liver. A case of readministration].
Topics: Acute Disease; Chemical and Drug Induced Liver Injury; Humans; Male; Middle Aged; Moxisylyte; Prosta | 1991 |
[Alpha adrenergic blocking agents in disorders of the bladder sphincter].
Topics: Adrenergic alpha-Antagonists; Adult; Female; Humans; Male; Moxisylyte; Nicergoline; Phenoxybenzamine | 1986 |
[The effect of moxisylyte hydrochloride in the symptomatic treatment of benign prostatic hyperplasia].
Topics: Adrenergic alpha-Antagonists; Aged; Drug Evaluation; Humans; Male; Middle Aged; Moxisylyte; Prostati | 1989 |